Company: SRPT
Filing Date: 2025-08-29
Form Type: 8-K
Source: 0001193125-25-192794
Chunk: 2

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-08-29
Form: 8-K
Item: Item 1.01
Chunk 2
---
 described in the Indenture, prior to the maturity date of the New Convertible Notes, holders of the New Convertible Notes will, subject to specified conditions, have the right, at their option, to require the Company to repurchase for cash all or a portion of their New Convertible Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest, if any, to, but not including, the fundamental change repurchase date. In addition, following certain corporate events that occur prior to the maturity date of the New Convertible Notes, the Company will increase the conversion rate for a holder who elects to convert its New Convertible Notes in connection with such corporate event.

The Indenture provides for customary events of default. In the case of an event of default with respect to the New Convertible Notes arising from specified events of bankruptcy or insolvency, all outstanding New Convertible Notes will become due and payable immediately without further action or notice. If any other event of default with respect to the New Convertible Notes under the Indenture occurs or is continuing, the Trustee or holders of at least 25% in aggregate principal amount of the then outstanding New Convertible Notes may declare the principal amount of the New Convertible Notes to be immediately due and payable.

The foregoing description of the Indenture and the New Convertible Notes does not purport to be complete and is qualified in its entirety by reference to each of the Indenture and form of Note, which are filed as Exhibits 4.1 and 4.2 to this Current Report on Form 8-K andare incorporated herein by reference.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-BalanceSheet Arrangement of a Registrant

The information set forth under Item 1.01 of this Current Report on Form8-Kis incorporated herein by reference.

Item 8.01 Other Events.

Concurrently with the issuance of the New Convertible Notes, the Company completed the previously announced private placement of 1,106,806 shares of Common Stock to J. Wood Capital Advisors LLC at a purchase price per share of $18.07, equal to the last reported sale price of our Common Stock on August 27, 2025.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                                           
                                                                                                                                                                                                                     
   Number                                                                                                                                                                                                            
      4